SEARCH

SEARCH BY CITATION

References

  • 1
    Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden. IV. Epidemiological trends 1959–1978. Acta Paediatr Scand 1984; 73: 43340.
  • 2
    Paneth N, Kiely J. The frequency of cerebral palsy: a review of population studies in industrialized nations since 1950. In: Stanley F, Alberman E, editors. The epidemiology of the cerebral palsies. Clinics in Developmental Medicine No. 87. London: Spastics International Medical Publications, 1984: 4656.
  • 3
    Stanley FJ. The changing face of cerebral palsy? Dev Med Child Neurol 1987; 29: 2635.
  • 4
    Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1986; 315: 816.
  • 5
    Stanley F, Blair E, Alberman E. Cerebral palsies: epidemiology and causal pathways. Clinics in Developmental Medicine No. 151. London: Mac Keith Press, 2000.
  • 6
    Kiely JL, Paneth N, Stein Z, Susser M. Cerebral palsy and newborn care. I: secular trends in cerebral palsy. Dev Med Child Neurol 1981; 23: 5338.
  • 7
    Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 2006; 33: 25167.
  • 8
    Hagberg B, Hagberg G, Olow I, von Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the Acta Paediatr birth year period 1987–1990. Acta Paediatr 1996; 85: 95460.
  • 9
    Stanley FJ, Watson L. Trends in perinatal mortality and cerebral palsy in Western Australia, 1967–1985. BMJ 1992; 304: 165863.
  • 10
    Doyle LW. Changing availability of neonatal intensive care for extremely low birthweight infants in Victoria over two decades. Med J Aust 2004; 181: 1369.
  • 11
    Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1998; 2: CD001079.
  • 12
    Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk for preterm birth. Cochrane Database Syst Rev 2006; 3: CD004454.
  • 13
    Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; 1: CD004661.
  • 14
    Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; 1: CD001146.
  • 15
    Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007; 357: 1893902.
  • 16
    Doyle LW, Roberts G, Anderson PJ, Victorian Infant Collaborative Study Group. Outcomes at age 2 years of infants <28 weeks’ gestational age born in Victoria in 2005. J Paediatr 2010; 156: 4953.
  • 17
    Stanley FJ, Alberman E. The epidemiology of the cerebral palsies. Clinics in Developmental Medicine No. 87. London: Spastics International Medical Publications, 1984.
  • 18
    Centers for Disease Control and Prevention. Measles, mumps, and rubella – vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR CDC Surveill Summ 1998; 47: 157.
  • 19
    Skari H, Bjornland K, Bjornstad-Ostensen A, Haugen G, Emblem R. Consequences of prenatal ultrasound diagnosis: a preliminary report on neonates with congenital malformations. Acta Obstet Gynecol Scand 1998; 77: 63542.
  • 20
    Andrew ME, Monagle P, de Veber G, Chan AKC. Thromboembolic disease and antithrombotic therapy in newborns. Hematology 2001; 35874.
  • 21
    Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349: 17659.
  • 22
    Alfirevic Z, Devane D, Gyte GML. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev 2006; 3: CD006066.
  • 23
    Bennett CC, Johnson A, Field DJ, Elbourne D. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet 2001; 357: 10946.
  • 24
    Torrance HL, Benders MJ, Derks JB, et al. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009; 124: 3507.
  • 25
    Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic–ischemic encephalopathy. Pediatrics 2009; 124: e21826.
  • 26
    Shah PS. Hypothermia: a systematic review and meta-analysis of clinical trials. Semin Fetal Neonatal Med 2010; 15: 23846.
  • 27
    Hagberg B, Hagberg G, Beckung E, Uvebrant P. Changing panorama of cerebal palsy in Sweden. VIII. Prevalence and origin in the birth year 1991–1994. Acta Paediatr 2001; 90: 2717.
  • 28
    Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden 1954–1970. I. Analysis of the general changes. Acta Paediatr Scand 1975; 64: 18792.
  • 29
    Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden. VI. Prevalence and origin during the birth year period 1983–1986. Acta Paediatr Scand 1993; 82: 38793.
  • 30
    Hagberg B, Hagberg G, Olow I, von Wendt L. The changing panorama of cerebral palsy in Sweden. V. The birth year period 1979–1982. Acta Paediatr Scand 1989; 78: 28390.
  • 31
    Himmelmann K, Hagberg G, Beckung E, Hagberg B, Uvebrant P. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995–1998. Acta Paediatr 2005; 94: 28794.
  • 32
    Parkes J, Dolk H, Hill N. Children and young people with cerebral palsy in Northern Ireland – birth years 1977–1997. A comprehensive report from the Northern Ireland Cerebral Palsy Register. Belfast: Queen’s University, 2005.
  • 33
    Ravn SH, Flachs EM, Uldall P. Cerebral palsy in eastern Denmark: declining birth prevalence but increasing numbers of unilateral cerebral palsy in birth-year period 1986–1998. Eur J Paediatr Neurol 2010; 14: 2148.
  • 34
    Robertson CMT, Watt M-J, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 2007; 297: 273340.
  • 35
    Surman G, Bonellie S, Chalmers J, et al. UKCP: a collaborative network of cerebral palsy registers in the United Kingdom. J Public Health 2006; 28: 14856.
  • 36
    Surman G, Newdick H, King A, Gallagher M, Kurinczuk JJ. 4 Child: four countries database of cerebral palsy, vision loss and hearing loss in children. Annual Report 2008, including data for births 1984–2002. Oxford: National Perinatal Epidemiology Unit, 2008.
  • 37
    Topp M, Uldall P, Langhoff-Roos J. Trend in cerebral palsy birth prevalence in Eastern Denmark: birth-year period 1979–1986. Paediatr Perinat Epidemiol 1997; 11: 45160.
  • 38
    Watson L, Blair E, Stanley F. Report of the western Australian cerebral palsy register. West Perth: Telethon Institute for Child Health Research, 2006.
  • 39
    Himmelmann K, Hagberg G, Uvebrant P. The changing panorama of cerebral palsy in Sweden. X. Prevalence and origin in the birth-year period 1999–2002. Acta Paediatr 2010; 99: 133743.
  • 40
    Nelson KB, Ellenberg JH. Children who ‘outgrew’ cerebral palsy. Pediatrics 1982; 69: 52936.
  • 41
    Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371: 2619.
  • 42
    Schendel DE. Cerebral palsy and preterm birth: how far have we come? Pediatr Health 2009; 3: 1113.